Canadá - inglês - Health Canada

auro pharma inc - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 4g; 0.5g - piperacillin (piperacillin sodium) 4g; tazobactam (tazobactam sodium) 0.5g - extended-spectrum penicillins

Canadá - inglês - Health Canada

eugia pharma inc. - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 2g; 0.25g - piperacillin (piperacillin sodium) 2g; tazobactam (tazobactam sodium) 0.25g

Canadá - inglês - Health Canada

eugia pharma inc. - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 3g; 0.375g - piperacillin (piperacillin sodium) 3g; tazobactam (tazobactam sodium) 0.375g

Canadá - inglês - Health Canada

eugia pharma inc. - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 4g; 0.5g - piperacillin (piperacillin sodium) 4g; tazobactam (tazobactam sodium) 0.5g

Filipinas - inglês - FDA (Food And Drug Administration)

eon pharmatek inc.; distributor: eon pharmatek inc. - piperacillin (as sodium) , tazobactam (as sodium) - powder for iv injection - 4 g/500 mg

Israel - inglês - Ministry of Health

neopharm (israel) 1996 ltd - piperacillin as sodium salt; tazobactam as sodium salt - powder for solution for infusion - piperacillin as sodium salt 4.0 g/vial; tazobactam as sodium salt 0.5 g/vial - tazobactam - - treatment of systemic and/or local infections caused by susceptible organisms.- piperacillin/tazobactam in combination with an aminoglycoside is indicated for the treatment of suspected bacterial infections in neutropenic adults and children above 2 years. - appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Israel - inglês - Ministry of Health

neopharm (israel) 1996 ltd - piperacillin as sodium salt; tazobactam as sodium salt - powder for solution for infusion - piperacillin as sodium salt 4.0 g/vial; tazobactam as sodium salt 0.5 g/vial - tazobactam - - treatment of systemic and/or local infections caused by susceptible organisms.- piperacillin/tazobactam in combination with an aminoglycoside is indicated for the treatment of suspected bacterial infections in neutropenic adults and children above 2 years. - appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Israel - inglês - Ministry of Health

neopharm (israel) 1996 ltd - piperacillin as sodium salt; tazobactam as sodium salt - powder for solution for infusion - piperacillin as sodium salt 4.0 g/vial; tazobactam as sodium salt 0.5 g/vial - tazobactam - - treatment of systemic and/or local infections caused by susceptible organisms.- piperacillin/tazobactam in combination with an aminoglycoside is indicated for the treatment of suspected bacterial infections in neutropenic adults and children above 2 years. - appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Israel - inglês - Ministry of Health

neopharm (israel) 1996 ltd - piperacillin as sodium salt; tazobactam as sodium salt - powder for solution for infusion - piperacillin as sodium salt 2.0 g/vial; tazobactam as sodium salt 0.25 g/vial - tazobactam - - treatment of systemic and/or local infections caused by susceptible organisms.- piperacillin/tazobactam in combination with an aminoglycoside is indicated for the treatment of suspected bacterial infections in neutropenic adults and children above 2 years. - appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Israel - inglês - Ministry of Health

neopharm (israel) 1996 ltd - piperacillin as sodium salt; tazobactam as sodium salt - powder for solution for infusion - piperacillin as sodium salt 2.0 g/vial; tazobactam as sodium salt 0.25 g/vial - tazobactam - - treatment of systemic and/or local infections caused by susceptible organisms.- piperacillin/tazobactam in combination with an aminoglycoside is indicated for the treatment of suspected bacterial infections in neutropenic adults and children above 2 years. - appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.